WS03.1 Optimization and testing of SPLUNC1-derived peptides with potent in vitro and in vivo ENaC inhibitory activity for the treatment of cystic fibrosis
2016
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI